Julia S. Gouw
Known title: DirectorCIK: 0001235498
Associated companies
Transaction History
| CV | ▲ Buy | Option Exercise | 2,022 | $15K | 6/30/2026 | View on chart |
| CV | ▲ Buy | Option Exercise | 2,887 | $31K | 12/31/2025 | View on chart |
| CV | ▲ Buy | Option Exercise | 2,022 | $15K | 6/30/2026 | View on chart |
| CV | ▲ Buy | Option Exercise | 2,887 | $31K | 12/31/2025 | View on chart |
We use analytics to understand how market-wall is used. No personal data is sold.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 28, 2026
CapsoVision Receives FDA Clearance for AI Highlights Tool
CapsoVision has secured FDA clearance for its AI Highlights reading tool on the CapsoCam Plus system. The approval allows the company to market the feature as a medical device, potentially expanding its use in clinical settings. The clearance may enhance the product’s value proposition and support future growth.
CapsoVision Receives FDA Clearance for AI Highlights Tool. CapsoVision has secured FDA clearance for its AI Highlights reading tool on the CapsoCam Plus system. The approval allows the company to market the feature as a medical device, potentially expanding its use in clinical settings. The clearance may enhance the product’s value proposition and support future growth.